Revvity (NYSE:RVTY) Given New $105.00 Price Target at Barclays

Key Points

• Barclays raised its price target on Revvity to $105 from $95 and kept an "equal weight" rating, implying roughly a 4.5% upside from the stock's current price.
• Analyst sentiment is mixed: the consensus average target is $107.73 with 4 Buys, 8 Holds and 1 Sell, giving Revvity an overall market rating of "Hold."
• Revvity beat quarterly estimates (EPS $1.06 vs. $1.02; revenue $711.1M vs. $704.1M), set FY2026 guidance of $5.20–$5.30 EPS, and trades near $100 with an $11.23B market cap.

Revvity (NYSE:RVTY - Get Free Report) had its price objective boosted by equities research analysts at Barclays from $95.00 to $105.00 in a research note issued on Thursday,Benzinga reports. The firm currently has an "equal weight" rating on the stock. Barclays's price target would indicate a potential upside of 4.49% from the stock's current price.

A number of other research analysts have also commented on the stock. Wells Fargo & Company boosted their price target on shares of Revvity from $107.00 to $110.00 and gave the company an "equal weight" rating in a research report on Tuesday, February 3rd. JPMorgan Chase & Co. dropped their price objective on Revvity from $96.00 to $90.00 and set a "neutral" rating for the company in a research note on Wednesday. Evercore boosted their target price on Revvity from $112.00 to $118.00 and gave the stock an "outperform" rating in a research report on Tuesday, February 3rd. Robert W. Baird set a $117.00 target price on Revvity in a research note on Wednesday. Finally, TD Cowen raised their price target on Revvity from $115.00 to $120.00 and gave the company a "buy" rating in a report on Wednesday. Four equities research analysts have rated the stock with a Buy rating, eight have issued a Hold rating and one has assigned a Sell rating to the stock. Based on data from MarketBeat.com, Revvity presently has an average rating of "Hold" and an average target price of $107.73.

Revvity Price Performance

Shares of RVTY traded up $1.40 during midday trading on Thursday, hitting $100.49. 915,616 shares of the company traded hands, compared to its average volume of 1,288,443. Revvity has a one year low of $81.22 and a one year high of $118.30. The firm has a market cap of $11.23 billion, a P/E ratio of 48.16, a PEG ratio of 1.96 and a beta of 1.05. The company has a debt-to-equity ratio of 0.37, a current ratio of 1.72 and a quick ratio of 1.40. The stock has a 50-day moving average of $90.28 and a 200-day moving average of $96.86.

Revvity (NYSE:RVTY - Get Free Report) last released its quarterly earnings data on Tuesday, May 5th. The company reported $1.06 EPS for the quarter, beating analysts' consensus estimates of $1.02 by $0.04. The company had revenue of $711.12 million during the quarter, compared to analyst estimates of $704.07 million. Revvity had a net margin of 8.26% and a return on equity of 8.00%. Revvity's revenue was up 7.0% compared to the same quarter last year. During the same period last year, the business earned $1.01 earnings per share. Revvity has set its FY 2026 guidance at 5.200-5.300 EPS. As a group, sell-side analysts predict that Revvity will post 5.4 EPS for the current fiscal year.

Hedge Funds Weigh In On Revvity

Institutional investors and hedge funds have recently made changes to their positions in the business. EdgePoint Investment Group Inc. lifted its stake in Revvity by 26.3% in the third quarter. EdgePoint Investment Group Inc. now owns 8,574,280 shares of the company's stock worth $751,536,000 after purchasing an additional 1,784,620 shares during the last quarter. Allspring Global Investments Holdings LLC increased its holdings in shares of Revvity by 127.0% in the fourth quarter. Allspring Global Investments Holdings LLC now owns 1,751,612 shares of the company's stock worth $171,921,000 after buying an additional 980,142 shares during the period. Norges Bank bought a new stake in shares of Revvity in the 4th quarter valued at about $80,382,000. Morgan Stanley lifted its stake in shares of Revvity by 29.6% in the 4th quarter. Morgan Stanley now owns 2,844,464 shares of the company's stock valued at $275,202,000 after acquiring an additional 650,083 shares during the last quarter. Finally, Dimensional Fund Advisors LP boosted its holdings in Revvity by 39.0% during the 3rd quarter. Dimensional Fund Advisors LP now owns 2,125,957 shares of the company's stock valued at $186,307,000 after acquiring an additional 596,436 shares during the period. Institutional investors own 86.65% of the company's stock.

About Revvity

Revvity, Inc is a global provider of technology-enabled solutions for the life sciences, diagnostics and applied markets. The company develops and supplies a range of products and services, including reagents and consumables, laboratory instruments, workflow automation, software analytics and technical support. Its portfolio supports applications in drug discovery, genomics, cell biology research, environmental and food safety testing, industrial quality control and clinical diagnostics.

Tracing its heritage to Perkin-Elmer, founded in 1937, Revvity began trading on the New York Stock Exchange under the ticker symbol RVTY in January 2024 following a corporate rebranding.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.